Biopharmaceutical company, Intarcia Therapeutics, Inc. chooses Novatek’s Environmental Monitoring for use at their Hayward Manufacturing site in California.
Novatek’s automated Environmental Monitoring software helps manufacturers evolve to a risk-based approach for their EM programs. The use of sampling data for the identification and mitigation of risk becomes a critical element in this process.
Novatek International is pleased to welcome Intarcia to our ever valued global Environmental Monitoring Software clients:
Lentigen , Ximedica, EirGenix Inc., KBI Biopharma, WuXi AppTec , Biocon, Hospira, Endo Pharmaceuticals, Pfizer, Medtronic, Ranbaxy, Biovest International, Inc., Lantheus Medical Imaging, DSM and many more.
Visit Novatek at the 2019 PDA Annual Meeting in San Diego, March 11-13, 2019 BOOTH # 404
About Intarcia Therapeutics, Inc.
Intarcia is a rapidly growing biopharmaceutical company developing innovative therapies that merge medicine and technology. We seek to transform the standard of care and improve patient outcomes in major therapeutic categories for serious chronic diseases, such as diabetes. We successfully completed our Phase 3 clinical trial program and submitted our New Drug Application filing for ITCA 650 in the U.S. in 2016.
